Frequently Asked Questions About Our Aesthetic & Weight Loss

Semaglutide is a GLP-1 medication that helps reduce appetite and promote weight loss when combined with diet and exercise.

Tirzepatide is a newer GLP-1 and GIP receptor agonist that supports significant weight loss and blood sugar control.

They work by slowing stomach emptying, reducing hunger, and regulating blood sugar, helping you eat less and lose weight safely.

Yes. Both are FDA-approved for weight management when prescribed by a healthcare professional and monitored for side effects.

Most patients notice weight loss within the first few weeks, with maximum results often seen after 3–6 months of consistent use.

Yes. Semaglutide and Tirzepatide work best when combined with a healthy diet and regular exercise.

Common side effects include nausea, vomiting, diarrhea, or mild constipation. Side effects usually improve over time.

They are generally prescribed for adults with a BMI ≥27 with weight-related conditions or BMI ≥30. A healthcare provider must assess suitability.

Both are once-weekly injections under the skin, which can be done at home after proper training.

Pricing varies depending on dosage, insurance coverage, and provider. Consult your healthcare provider for a personalized cost estimate.